JourneyMark 7 with Expanse Rider review

Yes, for the right buyer. This is a good annuity for someone who wants to set up protected lifetime income a few years down the road, values principal protection, and is comfortable committing money for seven years. It is less appealing for someone who mainly wants accumulation, expects to need regular access to large chunks of principal, or doesn't intend to actually turn the income rider on — because if you never activate income, you are paying a 1.00% rider fee for a feature you never use.

The main reason to buy JourneyMark 7 with the Expanse Rider is to build a future stream of guaranteed lifetime income that can't be outlived, while protecting principal from market downturns in the meantime. The secondary reason is the rider's deferral mechanics: the 10% first-year benefit-base bonus and the roll-up worth 200% of credited interest can grow the income base meaningfully if you wait several years before activating. For buyers worried about care costs, the income doubler — which can double your payout if you can't perform two of six daily-living activities — adds a layer of protection that a basic income annuity doesn't.

I think this annuity is best for someone in their fifties to mid-seventies (the issue-age window runs 45 to 80) who is using long-term, qualified or non-qualified retirement money to solve a future income problem rather than chase growth. It fits a buyer who expects to defer income for several years to let the benefit base build, wants the certainty of a guaranteed lifetime withdrawal, and likes the idea of a built-in care benefit. It is a poor fit for someone who wants short-term liquidity, the simplest possible annuity, or maximum accumulation — and it's not a fit for New York residents at all, since the contract isn't approved there.

You are not buying stock market upside, and you're not really buying the account value either. You are buying a lifetime income framework — the Expanse Rider — wrapped around a principal-protected annuity. The part that matters most is the benefit base, which is a separate accounting figure (not your cash you can walk away with) used only to calculate how much guaranteed income you can draw for life. Premiums get a 10% bonus to that benefit base in year one, and the base then grows under the roll-up rules for up to fifteen years before you activate income. Your account value, by contrast, grows based on index crediting and is what funds the death benefit and any cash surrender. Keeping those two numbers straight is the key to understanding this contract.

The Expanse Rider is a Guaranteed Lifetime Withdrawal Benefit, built into this version of JourneyMark 7 rather than offered as an option. At issue, all first-year premiums get a 10% bonus added to the benefit base — so $100,000 in premium starts you with a $110,000 benefit base. Before you turn income on, that base grows by 200% of the interest credited to your account value each index year, capped at a 25% increase per year, for up to fifteen years. In plain terms, the better your index strategies perform, the faster the income base climbs — and it climbs at twice the rate of the credited interest. When you eventually activate, your age and the size of the benefit base determine your guaranteed lifetime payout, which continues even if the account value runs to zero. The income doubler is layered on top: if you later can't perform two of six activities of daily living, your lifetime payout amount doubles (a 200% multiplier) for as long as you qualify, which functions as a built-in care benefit without a separate long-term-care contract.

The most meaningful secondary feature is the crediting menu paired with the enhanced liquidity. JourneyMark 7 offers six indexed strategies plus a fixed account, spanning the S&P 500, the Goldman Sachs Mariner index, and the Citi Flexi-Beta 5 Excess Return index, across annual point-to-point, biennial, and a 5-year quarterly high-water-mark method — all using participation rates rather than caps. As of the April 15, 2026 rate sheet, participation rates ran from 52% on the S&P 500 annual strategy up to 290% on the Citi Flexi-Beta 5 biennial strategy, with a 4.95% current fixed-account rate; the contract guarantees a minimum 10% participation rate across the indexed strategies. Those rates are a snapshot and will change, so ask for a current rate sheet before deciding. The other half of this is liquidity: the free withdrawal is 10% of account value annually after year one, which the materials note is double the base product's 5%. That extra access is unusually generous for an income FIA and softens the otherwise long lockup.

This is a contract for long-term retirement dollars, not money you might need soon. After year one you can take up to 10% of account value annually (noncumulative, $250 minimum) without penalty, which is more generous than most income FIAs. Anything above that during the surrender period is hit with a withdrawal charge that starts at 9% in years one and two and then steps down — 8.25%, 7.25%, 6.25%, 5%, and 4% — before disappearing after year seven. A Market Value Adjustment (MVA — a feature that raises or lowers your surrender penalty depending on how interest rates have moved since issue) also applies to excess withdrawals during the surrender period, which can swing the cost of a large early withdrawal in either direction. There are real relief features, though: required minimum distributions attributable to the contract that exceed the free amount are waived of surrender charges and the MVA (one RMD per index year), as are substantially equal periodic payments. Confinement (60-plus consecutive days) and terminal-illness (12 months or fewer life expectancy) waivers are available, though not in California.

The headline cost is the Expanse Rider fee: 1.00% annually currently, charged on the benefit base, with a contractual maximum of 1.50%. Because it's charged on the benefit base — which can grow well above your account value thanks to the bonus and roll-up — the dollar cost can climb over time even as a percentage stays flat. That's the trade: the fee buys you the 10% benefit-base bonus, the 200% roll-up, the income doubler, and an enhanced death benefit. Whether that's worth it comes down to whether you actually activate income — if you surrender early or never turn the rider on, you've paid for guarantees you didn't use. The good news on the base contract is that there is no separate M&E charge, no product fee, no administration charge, and no annual contract fee. The other tradeoffs are structural rather than line-item: participation rates limit how much index growth you keep, and the income-first design means the growth side isn't built to outrun a pure accumulation FIA.

Legal Entity: Integrity Life Insurance Company

Parent: Western & Southern Financial Group

AM Best Rating: A+

JourneyMark 7 is issued by Integrity Life Insurance Company, part of Western & Southern Financial Group, a long-established insurer carrying an A+ rating from AM Best. That financial backing matters for a contract whose entire value proposition is a guarantee you may not collect on for a decade or more.